Defining antibody targets in Streptococcus oralis infection.

Infection and Immunity
J BurnieR Matthews

Abstract

Immunoblotting of sera from 12 neutropenic patients with Streptococcus oralis septicemia and 18 patients with endocarditis due to viridans group streptococci revealed immunodominant S. oralis antigens at 85 and 180 kDa. The former cross-reacted with a mouse monoclonal antibody to hsp90. The latter was identified by sequencing positive clones obtained by screening a genomic expression library of S. oralis with pooled sera from patients who had been infected with S. oralis. Antibody eluted from one of these clones reacted with the 180-kDa antigen of S. oralis. Southern blotting confirmed the origin of the clone from S. oralis. The derived amino acid sequence showed 76.2% homology with the PAc protein precursor of Streptococcus mutans and 73.8% homology with the SpaA protein precursor of Streptococcus sobrinus. Epitope mapping of the derived amino acid sequence with sera from patients with viridans group streptococcal endocarditis delineated nine epitopes. Peptides 1 (TMYPNRQPGSGWDSS) and 2 (WYSLNGKIRAVDVPK), representing two of these epitopes, and peptide 3 (YEVEKPLEPAPVAPS), representing the repeat proline region, were synthesized. These three peptides were used to screen a phage antibody display library derived from a patient w...Continue Reading

References

Jan 1, 1978·Medical and Pediatric Oncology·P A PizzoF G Witebsky
Jun 1, 1992·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·E PotgieterL J Chalkley
Jun 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L S EltingB H Keefe
Jul 1, 1990·Journal of Bacteriology·R M GoldschmidtR Curtiss
Sep 1, 1991·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J T van der MeerM F Michel
Jan 1, 1991·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A D BurdenN Thatcher
Oct 1, 1991·Journal of Clinical Microbiology·J P Burnie, R C Matthews
Jan 24, 1991·Nature·G Winter, C Milstein
Jan 1, 1991·Archives of Oral Biology·S J FillerJ R McGhee
Jan 1, 1990·Protein Engineering·A J Bleasby, J C Wootton
Sep 24, 1987·Journal of Immunological Methods·H M GeysenP G Schoofs
Jul 1, 1989·The Journal of Cell Biology·H W Davidson, C Watts
Feb 1, 1988·Journal of Molecular Recognition : JMR·H M GeysenS J Rodda
Oct 1, 1987·Journal of Clinical Pathology·J P BurnieW Lees
Sep 1, 1987·European Journal of Epidemiology·F MenichettiS Pauluzzi
Mar 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·R A Young, R W Davis
Jan 1, 1994·FEMS Immunology and Medical Microbiology·A M al-DughaymJ P Burnie
Oct 1, 1993·The Journal of Experimental Medicine·C Watts, A Lanzavecchia
May 1, 1995·Infection and Immunity·S F Lee
Mar 1, 1994·Journal of Medical Microbiology·D BeightonB A Oppenheim
Sep 1, 1993·Journal of Medical Microbiology·C W DouglasF E Preston

❮ Previous
Next ❯

Citations

Aug 26, 2009·Oral Microbiology and Immunology·M Matsumoto-NakanoT Ooshima
Sep 5, 2002·Microbiology and Molecular Biology Reviews : MMBR·Paul E KolenbranderRobert J Palmer
Apr 16, 1999·Oral Microbiology and Immunology·J D Rudney, C J Larson
Mar 1, 2008·Proteomics. Clinical Applications·Jason N ColeMark J Walker
May 4, 1999·FEMS Immunology and Medical Microbiology·P Williamson, R Matthews
Jul 12, 2002·FEMS Immunology and Medical Microbiology·James BurnieRuth Matthews
Nov 9, 2002·FEMS Immunology and Medical Microbiology·Foroogh NejatollahiJames P Burnie
Jan 31, 2006·Microbes and Infection·Kazuhiko NakanoTakashi Ooshima

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.